ProCE Banner Activity

Oral Soluble Guanylate Cyclase Stimulators Associated With Reduced Hospitalizations for Heart Failure

Slideset Download
Conference Coverage
In meta-analysis of 8 randomized placebo-controlled clinical trials, addition of oral sGC stimulators to guideline-directed medical therapy for heart failure reduced risk of hospitalization for heart failure vs placebo; net adverse events not significantly increased over placebo.

Released: June 29, 2021

Expiration: June 28, 2022

No longer available for credit.

Share

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

Merck